Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
16-31 December 2008  
Untitled Document
Sections

Market
Management
Research
IPC Special
Pharma Life
Express Biotech

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Express Healthcare
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    MARKET - The Business of Pharmaceuticals
 

Pharma poised to withstand recession
As economic recession plagues various industries, robust demand could insulate the Indian pharma industry to withstand these pressures. Arshiya Khan analyses the impact

OSE commences CRO operations in India
Oncology Services Europe (OSE), a full service Contract Research Organisation (CRO), specialised in clinical drug development in oncology launched its India operations with establishment of its independent clinical services company, Oncology Services India (OSI), in Ahmedabad, Gujarat

DIPSAR to get university status
Delhi will soon have its own university dedicated to pharmaceutical sciences. “This will be the first university of pharmaceutical sciences in this country and perhaps in the whole world,” said Professor S S Agrawal, Director and Head, Department of Pharmacology, DIPSAR

EDAL acquires majority stake in India Foils
ESS DEE Aluminium Ltd (EDAL), a leading manufacturer and supplier of Aluminium foil and PVC based primary packaging company, has recently acquired an 85-90 percent stake in India Foils Ltd (IFL), a Vedanta Group Company, thereby, making it a subsidiary

Tata Strategic partners with Pharma Alliance International
Tata Strategic Management Group (Tata Strategic), India’s management consulting firm, has recently tied up with UK-based company Pharma Alliance International (Pharma Alliance) to offer management consulting services in the pharmaceutical industry

Lupin launches Ivabrad
Lupin has received Drug Controller General of India (DCGI) approval to launch India’s first selective and specific sinus node I channel inhibitor; Ivabrad (ivabradine)

UK Government and Clinton Foundation to help Indian pharma companies
The UK Secretary of State for International Develo-pment, Douglas Alexander MP announced that the UK is working with the Clinton Foundation to help Indian pharmaceutical companies

Asia Pharma Expo 2009
Asia Pharma Expo 2009, an international exhibition on South Asian pharmaceutical industry, will be happening for the fifth time at the Bangladesh-China Friendship Conference Center, Dhaka, Bangladesh, on January 22-24, 2009

ISCR’s second annual conference
Indian Society for Clinical Research (ISCR) brings you the 2nd edition of its annual conference from January 11th -12th, 2009, at Taj Lands End, Mumbai

Event Brief

Breakthrough in the treatment of migraine
A public seminar on new dimension in the treatment of migraine was conducted on 20th November 2008 at Indian Merchants Chamber, Mumbai as an initiative of Ipca Laboratories


Untitled Document
Untitled Document
© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.